Skip to content
10-Q

Quarterly Report

Echo Therapeutics, Inc.

0001654954-16-004120

← back to feed
Filed
Nov 16, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Oct 30, 2016 12M sh
Operating Cash Flow Q3 2016 · Sep 30, 2016 −$4.17M
Operating Cash Flow restated Q3 2016 · Sep 30, 2015 −$4.43M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $172.73K
Cash And Equivalents Q3 2016 · Dec 31, 2015 $56.21K
Cash And Equivalents Q3 2016 · Sep 30, 2015 $3.23K
Cash And Equivalents Q3 2016 · Dec 31, 2014 $1.28M
Stockholders Equity Q3 2016 · Sep 30, 2016 −$6.29M
Stockholders Equity Q3 2016 · Dec 31, 2015 −$2.53M
Current Liabilities Q3 2016 · Sep 30, 2016 $7.27M
Current Liabilities Q3 2016 · Dec 31, 2015 $3.24M
Total Liabilities Q3 2016 · Sep 30, 2016 $7.36M
Total Liabilities Q3 2016 · Dec 31, 2015 $3.33M
Current Assets Q3 2016 · Sep 30, 2016 $401.95K
Current Assets Q3 2016 · Dec 31, 2015 $300.74K
Total Assets Q3 2016 · Sep 30, 2016 $1.08M
Total Assets Q3 2016 · Dec 31, 2015 $805.09K
Eps Diluted Q3 2016 · Sep 30, 2016 −$0.11
Eps Diluted Q3 2016 · Sep 30, 2016 −$0.98
Eps Diluted Q3 2016 · Sep 30, 2015 −$0.16
Eps Diluted Q3 2016 · Sep 30, 2015 −$1.86
Eps Basic Q3 2016 · Sep 30, 2016 $0.07
Eps Basic Q3 2016 · Sep 30, 2016 −$0.98
Eps Basic Q3 2016 · Sep 30, 2015 −$0.16
Eps Basic Q3 2016 · Sep 30, 2015 −$1.86
Sga Expense Q3 2016 · Sep 30, 2016 $1.2M
Sga Expense Q3 2016 · Sep 30, 2016 $2.93M
Sga Expense restated Q3 2016 · Sep 30, 2015 $820.66K
Sga Expense restated Q3 2016 · Sep 30, 2015 $3.82M
Rd Expense Q3 2016 · Sep 30, 2016 $588.55K
Rd Expense Q3 2016 · Sep 30, 2016 $1.94M
Rd Expense restated Q3 2016 · Sep 30, 2015 $559K
Rd Expense restated Q3 2016 · Sep 30, 2015 $2.03M
Net Income Q3 2016 · Sep 30, 2016 $794.17K
Net Income Q3 2016 · Sep 30, 2016 −$4.77M
Net Income Q3 2016 · Sep 30, 2015 −$1.78M
Net Income Q3 2016 · Sep 30, 2015 −$20.92M
Operating Income Q3 2016 · Sep 30, 2016 −$1.81M
Operating Income Q3 2016 · Sep 30, 2016 −$4.95M
Operating Income Q3 2016 · Sep 30, 2015 −$1.46M
Operating Income restated Q3 2016 · Sep 30, 2015 −$16.23M
Revenue Q3 2016 · Sep 30, 2016 $0
Revenue Q3 2016 · Sep 30, 2016 $0
Revenue Q3 2016 · Sep 30, 2015 $0
Revenue Q3 2016 · Sep 30, 2015 $0